Gabapentin in alcohol dependence

Journal of Pharmacy Technology

Volumn 31, Issue 4, 2015, Pages 177-183

  Greutman, Morgan D ^a   Gales, Mark A ^a,b,c   Gales, Barry J ^a,b,c  

^a SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

^b Great Plains Family Medicine Residency Program   (United States)

^c INTEGRIS BAPTIST MEDICAL CENTER   (United States)

Author keywords

Abstinence; Alcohol dependence; Alcoholism; Craving; Gabapentin

Indexed keywords

DIAZEPAM; FLUMAZENIL; GABAPENTIN; LORAZEPAM; NALTREXONE; PLACEBO; VALPROIC ACID;

ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; DRUG TOLERABILITY; HUMAN; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

EID: 84943271563     PISSN: 87551225     EISSN: 15494810     Source Type: Journal    
DOI: 10.1177/8755122515575543     Document Type: Article

References (22)

1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009; 373: 2223-2233. doi: 10.1016/S0140-6736(09)60746-7.
2. World Health Organization. Alcohol fact sheet. http://www.who.int/mediacentre/factsheets/fs349/en/. Accessed October 30, 2014.
3. Muncie HL, Yasinian Y, Oge' L. Outpatient management of alcohol withdrawal syndrome. Am Fam Physician. 2013; 88: 589-595.
4. Center for Disease Control and Prevention. Chronic diseases: the leading causes of death and disability in the United States. http://www.cdc.gov/chronicdisease/overview/. Accessed October 30, 2014.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 2000.
6. Dawson DA, Grant BF, Stinson FS, Chou PS, Huang B, Ruan WJ. Recovery from DSM-IV alcohol dependence. Addiction. 2005; 100: 281-292. doi: 10.1111/j.1360-0443.2004.00964.x.
7. Lexicomp. Gabapentin. Hudson, OH: Wolters Kluwer; August 25, 2014.
8. Leggio L, Kenna GA, Swift RM. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1106-1117. doi: 10.1016/j.pnpbp.2007.09.021.
9. Myrick H, Anton R, Voronin K, Wang W, Henderson S. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007; 31: 221-227. doi: 10.1111/j.1530-0277.2006.00299.x.
10. Stock CJ, Carpenter L, Ying J, Greene T. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother. 2013; 47: 961-969. doi: 10.1345/aph.1R751.
11. Schacht JP, Randall PK, Waid LR, et al. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011; 35: 2030-2038. doi: 10.1111/j.15300277.2011.01554.x.
12. Myrick H, Malcolm R, Randall PK, et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009; 33: 1582-1588. doi: 10.1111/j.1530-0277.2009.00986.x.
13. Malcolm R, Myrick LH, Veatch LM, Boyle E, Randall PK. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007; 3: 24-32.
14. Bonnet U, Hamzavi-Abedi R, Specka M, Wiltfang J, Lieb B, Scherbaum N. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol Alcohol. 2010; 45: 143-145. doi: 10.1093/alcalc/agp085.
15. Myrick H, Malcolm R, Brady KT. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry. 1998; 155: 1632.
16. Chatterjee CR, Ringold AL. A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin. J Clin Psychiatry. 1999; 60: 617.
17. Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2007; 68: 1691-1700.
18. Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res. 2008; 32: 1429-1438. doi: 10.1111/j.1530-0277.2008.00706.x.
19. Trevisan LS, Ralevski E, Keegan K, et al. Alcohol detoxification and relapse prevention using valproic acid versus gabapentin in alcohol-dependent patients. Addict Disord Their Treatment. 2008; 7: 119-128. doi: 10.1097/ADT.0b013e31812e6a3c.
20. Anton RF, Myrick H, Baros AM, et al. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009; 29: 334-342. doi: 10.1097/JCP.0b013e3181aba6a4.
21. Anton RF, Myrick H, Wright TM, et al. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011; 168: 709-717. doi: 10.1176/appi.ajp.2011.10101436.
22. Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Internal Med. 2014; 174: 70-77. doi: 10.1001/jamainternmed.2013.11950